FDA update on brand drugs for October 29, 2009
This is a discussion on FDA update on brand drugs for October 29, 2009 within the New Brand Drug Approvals by Month forum, part of the New Drug Approvals and Pipeline category; Arzerra (ofatumumab) by GlaxoSmithKline Accelerated approval: CD20-directed cytolytic monoclonal antibody indicated for the treatment of patients with chronic lymphocytic ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
10-29-2009, 10:47 AM
|
||||
|
||||
FDA update on brand drugs for October 29, 2009
Arzerra (ofatumumab) by GlaxoSmithKline
Accelerated approval: CD20-directed cytolytic monoclonal antibody indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) refractory to fludarabine and alemtuzumab •Link to GSK press release 10/09Sources: U.S. Food and Drug Administration. Drugs@FDA. Available at: Drugs@FDA U.S. Food and Drug Administration. Center for Biologics Evaluation and Research. Available at: CBER Last edited by chantell.reagan : 10-29-2009 at 11:16 AM. 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA update on brand drugs for October 22, 2009 | chantell.reagan | New Brand Drug Approvals by Month | 0 | 10-22-2009 08:18 AM |
| FDA update on brand drugs for October 15, 2009 | chantell.reagan | New Brand Drug Approvals by Month | 0 | 10-15-2009 08:35 AM |
| FDA update on brand drugs for October 7, 2009 | chantell.reagan | New Brand Drug Approvals by Month | 0 | 10-08-2009 12:38 PM |
| FDA update on brand drugs for October 22, 2008 | chantell.reagan | New Brand Drug Approvals by Month | 0 | 10-23-2008 09:54 AM |
| FDA update on brand drugs for October 8, 2008 | chantell.reagan | New Brand Drug Approvals by Month | 0 | 10-09-2008 11:07 AM |
© 2008 DrugManagementForum™ powered by |
 |